Yahoo Finance Insider Stock Buying Reaches US$9.30m On Privia Health Group
In the last year, multiple insiders have substantially increased their holdings of Privia Health Group, Inc. (NASDAQ:PRVA) stock, indicating that insiders' optimism about the company's prospects has increased.
Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.
Check out our latest analysis for Privia Health Group
Privia Health Group Insider Transactions Over The Last Year
Notably, that recent purchase by Independent Director Adam Boehler was not the only time they bought Privia Health Group shares this year. Earlier in the year, they paid US$16.43 per share in a US$9.0m purchase. So it's clear an insider wanted to buy, at around the current price, which is US$17.39. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. Happily, the Privia Health Group insiders decided to buy shares at close to current prices.
In the last twelve months insiders purchased 572.02k shares for US$9.3m. But insiders sold 49.39k shares worth US$898k. In total, Privia Health Group insiders bought more than they sold over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!
Privia Health Group is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
Insiders At Privia Health Group Have Bought Stock Recently
At Privia Health Group,over the last quarter, we have observed quite a lot more insider buying than insider selling. In total, two insiders bought US$9.3m worth of shares in that time. On the other hand, insiders netted US$898k by selling. We think insiders may be optimistic about the future, since insiders have been net buyers of shares.
Insider Ownership
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. Privia Health Group insiders own about US$173m worth of shares (which is 8.3% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
So What Do The Privia Health Group Insider Transactions Indicate?
It is good to see recent purchasing. And the longer term insider transactions also give us confidence. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Privia Health Group. Nice! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Privia Health Group. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Privia Health Group.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
